Leucogen
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Leucogen, covering 2023-03-22 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: A Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLC [NA]